Molecular Imaging and Biology

, Volume 13, Issue 6, pp 1278–1283 | Cite as

The Relationship between Patients’ Serum Glucose Levels and Metabolically Active Brown Adipose Tissue Detected by PET/CT

  • Heather A. Jacene
  • Christian C. Cohade
  • Zhe Zhang
  • Richard L. WahlEmail author
Research Article



To compare blood glucose levels in patients with or without “detectable” brown adipose tissue (BAT) using 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography (FDG PET/CT).


Nine hundred eight patients had PET/CT scans and were previously identified as having, or not having, FDG uptake in BAT. The original database was retrospectively reviewed for blood glucose level and body mass index (BMI) at the time of imaging. Blood glucose levels were compared between patients with or without FDG uptake in BAT, adjusting for age, sex, and BMI.


Fifty-six patients (6.2%) had FDG uptake in BAT. In the univariate analysis, patients without FDG uptake in BAT had a higher risk of glucose ≥100 mg/dL (odds ratio 3.4, 95% CI = 1.6-7.3; P = 0.0007). After adjustment for age, sex, BMI, and significant interaction of sex and BMI, patients without BAT tended to have a higher risk of glucose ≥100 mg/dL, although not statistically significant (odds ratio = 1.6, 95% CI = 0.7-3.6; P = 0.268).


Although causal relationships are not specified, the data suggest that BAT uptake, glucose levels, BMI, sex, and age are inter-related and the possibility that presence of “detectable” BAT is protective against diabetes and obesity. FDG PET/CT may be a vital tool for further investigations of diabetes and obesity.

Key words

Brown fat BAT Glucose FDG “USA”-Fat PET Brown adipose tissue 


Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Rosen ED, Spiegelman BM (2000) Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145–171PubMedCrossRefGoogle Scholar
  2. 2.
    Cohade C, Osman M, Pannu HK, Wahl RL (2003) Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT. J Nucl Med 44:170–176PubMedGoogle Scholar
  3. 3.
    Hany TF, Gharehpapagh E, Kamel EM, Buck A, Himms-Hagen J, von Schulthess GK (2002) Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29:1393–1398PubMedCrossRefGoogle Scholar
  4. 4.
    Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293:E444–E452PubMedCrossRefGoogle Scholar
  5. 5.
    van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM et al (2009) Cold-activated brown adipose tissue in healthy men. N Engl J Med 360:1500–1508PubMedCrossRefGoogle Scholar
  6. 6.
    Cypess AM, Lehman S, Williams G et al (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509–1517PubMedCrossRefGoogle Scholar
  7. 7.
    Virtanen KA, Lidell ME, Orava J et al (2009) Functional brown adipose tissue in healthy adults. N Engl J Med 360:1518–1525PubMedCrossRefGoogle Scholar
  8. 8.
    Bar-Shalom R, Gaitini D, Keidar Z, Israel O (2004) Non-malignant FDG uptake in infradiaphragmatic adipose tissue: a new site of physiological tracer biodistribution characterised by PET/CT. Eur J Nucl Med Mol Imaging 31:1105–1113PubMedCrossRefGoogle Scholar
  9. 9.
    Baba S, Engles JM, Huso DL, Ishimori T, Wahl RL (2007) Comparison of uptake of multiple clinical radiotracers into brown adipose tissue under cold-stimulated and nonstimulated conditions. J Nucl Med 48:1715–1723PubMedCrossRefGoogle Scholar
  10. 10.
    Baba S, Tatsumi M, Ishimori T, Lilien DL, Engles JM, Wahl RL (2007) Effect of nicotine and ephedrine on the accumulation of 18F-FDG in brown adipose tissue. J Nucl Med 48:981–986PubMedCrossRefGoogle Scholar
  11. 11.
    Tatsumi M, Engles JM, Ishimori T, Nicely O, Cohade C, Wahl RL (2004) Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. J Nucl Med 45:1189–1193PubMedGoogle Scholar
  12. 12.
    Cohade C, Mourtzikos KA, Wahl RL (2003) "USA-Fat": prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 44:1267–1270PubMedGoogle Scholar
  13. 13.
    Hamann A, Benecke H, Le Marchand-Brustel Y, Susulic VS, Lowell BB, Flier JS (1995) Characterization of insulin resistance and NIDDM in transgenic mice with reduced brown fat. Diabetes 44:1266–1273PubMedCrossRefGoogle Scholar
  14. 14.
    Hamann A, Flier JS, Lowell BB (1996) Decreased brown fat markedly enhances susceptibility to diet-induced obesity, diabetes, and hyperlipidemia. Endocrinology 137:21–29PubMedCrossRefGoogle Scholar
  15. 15.
    Lowell BB, Susulic V, Hamann A et al (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 366:740–742PubMedCrossRefGoogle Scholar
  16. 16.
    Ortmann S, Prinzler J, Klaus S (2003) Self-selected macronutrient diet affects energy and glucose metabolism in brown fat-ablated mice. Obes Res 11:1536–1544PubMedCrossRefGoogle Scholar
  17. 17.
    Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diab Care 26:3160–3167CrossRefGoogle Scholar
  18. 18.
    National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res 6:51 S-209 S.Google Scholar
  19. 19.
    Yeung HW, Grewal RK, Gonen M, Schoder H, Larson SM (2003) Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false positives for PET. J Nucl Med 44:1789–1796PubMedGoogle Scholar
  20. 20.
    Collins S, Daniel KW, Rohlfs EM, Ramkumar V, Taylor IL, Gettys TW (1994) Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6 J ob/ob) mice. Mol Endocrinol 8:518–527PubMedCrossRefGoogle Scholar
  21. 21.
    Marette A, Mauriege P, Despres JP, Tulp OL, Bukowiecki LJ (1993) Norepinephrine- and insulin-resistant glucose transport in brown adipocytes from diabetic SHR/N-cp rats. Am J Physiol 265:R577–R583PubMedGoogle Scholar
  22. 22.
    Ghorbani M, Himms-Hagen J (1997) Appearance of brown adipocytes in white adipose tissue during CL 316, 243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int J Obes Relat Metab Disord 21:465–475PubMedCrossRefGoogle Scholar
  23. 23.
    Williams G, Kolodny GM (2008) Methods for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR Am J Roentgenol 190:1406–1409PubMedCrossRefGoogle Scholar
  24. 24.
    Rothwell NJ, Stock MJ (1979) A role for brown adipose tissue in diet-induced thermogenesis. Nature 281:31–35PubMedCrossRefGoogle Scholar

Copyright information

© Academy of Molecular Imaging and Society for Molecular Imaging 2010

Authors and Affiliations

  • Heather A. Jacene
    • 1
  • Christian C. Cohade
    • 1
    • 2
  • Zhe Zhang
    • 3
  • Richard L. Wahl
    • 1
    Email author
  1. 1.Russell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear MedicineJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.Departement de Médecine Nucléaire, Centre Hospitalier de l’Université de MontréalMontréalCanada
  3. 3.Division of Oncology Biostatistics, The Sidney Kimmel Comprehensive Cancer CenterThe Johns Hopkins UniversityBaltimoreUSA

Personalised recommendations